244 related articles for article (PubMed ID: 30460891)
1. Frontostriatal functional connectivity and striatal dopamine synthesis capacity in schizophrenia in terms of antipsychotic responsiveness: an [
Kim S; Jung WH; Howes OD; Veronese M; Turkheimer FE; Lee YS; Lee JS; Kim E; Kwon JS
Psychol Med; 2019 Nov; 49(15):2533-2542. PubMed ID: 30460891
[TBL] [Abstract][Full Text] [Related]
2. Presynaptic Dopamine Capacity in Patients with Treatment-Resistant Schizophrenia Taking Clozapine: An [
Kim E; Howes OD; Veronese M; Beck K; Seo S; Park JW; Lee JS; Lee YS; Kwon JS
Neuropsychopharmacology; 2017 Mar; 42(4):941-950. PubMed ID: 27857125
[TBL] [Abstract][Full Text] [Related]
3. Aberrant striatal dopamine links topographically with cortico-thalamic dysconnectivity in schizophrenia.
Avram M; Brandl F; Knolle F; Cabello J; Leucht C; Scherr M; Mustafa M; Koutsouleris N; Leucht S; Ziegler S; Sorg C
Brain; 2020 Dec; 143(11):3495-3505. PubMed ID: 33155047
[TBL] [Abstract][Full Text] [Related]
4. Dopamine synthesis capacity in patients with treatment-resistant schizophrenia.
Demjaha A; Murray RM; McGuire PK; Kapur S; Howes OD
Am J Psychiatry; 2012 Nov; 169(11):1203-10. PubMed ID: 23034655
[TBL] [Abstract][Full Text] [Related]
5. The Relationship Between Frontostriatal Connectivity and Striatal Dopamine Function in Schizophrenia: An 18F-DOPA PET and Diffusion Tensor Imaging Study in Treatment Responsive and Resistant Patients.
Shin S; Jung WH; McCutcheon R; Veronese M; Beck K; Lee JS; Lee YS; Howes OD; Kim E; Kwon JS
Psychiatry Investig; 2022 Jul; 19(7):570-579. PubMed ID: 35903059
[TBL] [Abstract][Full Text] [Related]
6. Altered connectivity between striatal and extrastriatal regions in patients with schizophrenia on maintenance antipsychotics: an [
Kim JH; Cumming P; Son YD; Kim HK; Joo YH; Kim JH
Synapse; 2018 Dec; 72(12):e22064. PubMed ID: 30063263
[TBL] [Abstract][Full Text] [Related]
7. Reduced striatal dopamine synthesis capacity in patients with schizophrenia during remission of positive symptoms.
Avram M; Brandl F; Cabello J; Leucht C; Scherr M; Mustafa M; Leucht S; Ziegler S; Sorg C
Brain; 2019 Jun; 142(6):1813-1826. PubMed ID: 31135051
[TBL] [Abstract][Full Text] [Related]
8. Presynaptic Dopamine Synthesis Capacity in Schizophrenia and Striatal Blood Flow Change During Antipsychotic Treatment and Medication-Free Conditions.
Eisenberg DP; Yankowitz L; Ianni AM; Rubinstein DY; Kohn PD; Hegarty CE; Gregory MD; Apud JA; Berman KF
Neuropsychopharmacology; 2017 Oct; 42(11):2232-2241. PubMed ID: 28387222
[TBL] [Abstract][Full Text] [Related]
9. Dopamine and Glutamate in Antipsychotic-Responsive Compared With Antipsychotic-Nonresponsive Psychosis: A Multicenter Positron Emission Tomography and Magnetic Resonance Spectroscopy Study (STRATA).
Egerton A; Murphy A; Donocik J; Anton A; Barker GJ; Collier T; Deakin B; Drake R; Eliasson E; Emsley R; Gregory CJ; Griffiths K; Kapur S; Kassoumeri L; Knight L; Lambe EJB; Lawrie SM; Lees J; Lewis S; Lythgoe DJ; Matthews J; McGuire P; McNamee L; Semple S; Shaw AD; Singh KD; Stockton-Powdrell C; Talbot PS; Veronese M; Wagner E; Walters JTR; Williams SR; MacCabe JH; Howes OD
Schizophr Bull; 2021 Mar; 47(2):505-516. PubMed ID: 32910150
[TBL] [Abstract][Full Text] [Related]
10. Functional network dysconnectivity as a biomarker of treatment resistance in schizophrenia.
McNabb CB; Tait RJ; McIlwain ME; Anderson VM; Suckling J; Kydd RR; Russell BR
Schizophr Res; 2018 May; 195():160-167. PubMed ID: 29042073
[TBL] [Abstract][Full Text] [Related]
11. Cognitive impairment in schizophrenia is associated with prefrontal-striatal functional hypoconnectivity and striatal dopaminergic abnormalities.
Yang KC; Yang BH; Liu MN; Liou YJ; Chou YH
J Psychopharmacol; 2024 Jun; 38(6):515-525. PubMed ID: 38853592
[TBL] [Abstract][Full Text] [Related]
12. [Cognition, schizophrenia and the effect of antipsychotics].
Stip E
Encephale; 2006; 32(3 Pt 1):341-50. PubMed ID: 16840928
[TBL] [Abstract][Full Text] [Related]
13. Glutamatergic neurometabolites in clozapine-responsive and -resistant schizophrenia.
Goldstein ME; Anderson VM; Pillai A; Kydd RR; Russell BR
Int J Neuropsychopharmacol; 2015 Jan; 18(6):. PubMed ID: 25603859
[TBL] [Abstract][Full Text] [Related]
14. The Effects of Antipsychotic Treatment on Presynaptic Dopamine Synthesis Capacity in First-Episode Psychosis: A Positron Emission Tomography Study.
Jauhar S; Veronese M; Nour MM; Rogdaki M; Hathway P; Natesan S; Turkheimer F; Stone J; Egerton A; McGuire P; Kapur S; Howes OD
Biol Psychiatry; 2019 Jan; 85(1):79-87. PubMed ID: 30122287
[TBL] [Abstract][Full Text] [Related]
15. Striatal dopamine synthesis capacity in twins discordant for schizophrenia.
Shotbolt P; Stokes PR; Owens SF; Toulopoulou T; Picchioni MM; Bose SK; Murray RM; Howes OD
Psychol Med; 2011 Nov; 41(11):2331-8. PubMed ID: 21426628
[TBL] [Abstract][Full Text] [Related]
16. The striatal and extrastriatal D2/D3 receptor-binding profile of clozapine in patients with schizophrenia.
Gründer G; Landvogt C; Vernaleken I; Buchholz HG; Ondracek J; Siessmeier T; Härtter S; Schreckenberger M; Stoeter P; Hiemke C; Rösch F; Wong DF; Bartenstein P
Neuropsychopharmacology; 2006 May; 31(5):1027-35. PubMed ID: 16237387
[TBL] [Abstract][Full Text] [Related]
17. Changes in corticostriatal connectivity and striatal tissue iron associated with efficacy of clozapine for treatment‑resistant schizophrenia.
Blazer A; Chengappa KNR; Foran W; Parr AC; Kahn CE; Luna B; Sarpal DK
Psychopharmacology (Berl); 2022 Aug; 239(8):2503-2514. PubMed ID: 35435461
[TBL] [Abstract][Full Text] [Related]
18. The relationship between grey matter volume and striatal dopamine function in psychosis: a multimodal
D'Ambrosio E; Jauhar S; Kim S; Veronese M; Rogdaki M; Pepper F; Bonoldi I; Kotoula V; Kempton MJ; Turkheimer F; Kwon JS; Kim E; Howes OD
Mol Psychiatry; 2021 Apr; 26(4):1332-1345. PubMed ID: 31690805
[TBL] [Abstract][Full Text] [Related]
19. The affinity of antipsychotic drugs to dopamine and serotonin 5-HT
Tollens F; Gass N; Becker R; Schwarz AJ; Risterucci C; Künnecke B; Lebhardt P; Reinwald J; Sack M; Weber-Fahr W; Meyer-Lindenberg A; Sartorius A
Eur Neuropsychopharmacol; 2018 Sep; 28(9):1035-1046. PubMed ID: 30006253
[TBL] [Abstract][Full Text] [Related]
20. Determinants of treatment response in first-episode psychosis: an
Jauhar S; Veronese M; Nour MM; Rogdaki M; Hathway P; Turkheimer FE; Stone J; Egerton A; McGuire P; Kapur S; Howes OD
Mol Psychiatry; 2019 Oct; 24(10):1502-1512. PubMed ID: 29679071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
